A phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer
Authors
Morgan, Robert DavidJayson, Gordon C
Banerjee, S
Clamp, Andrew R
Lyon, A
Ryder, W David J
Hutson, R
Mescallado, Nerissa
Aguilar, C
Taylor, S
Tugwood, Jonathan D
Hall, M
Dive, Caroline
Rustin, G
Affiliation
Medical Oncology, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2018
Metadata
Show full item recordCitation
Morgan RD, Jayson GC, Banerjee S, Clamp AR, Lyon AR, Ryder WD, et al. 956PA phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer. Ann Oncol. 2018;29(suppl_8):342.Journal
Annals of OncologyDOI
10.1093/annonc/mdy285.164Additional Links
https://dx.doi.org/10.1093/annonc/mdy285.164Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy285.164